Isao Kanatani
Overview
Explore the profile of Isao Kanatani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishiyama R, Kanatani I, Oka H, Ichijima K
Hinyokika Kiyo
. 2012 Jun;
58(4):197-201.
PMID: 22684260
A 60-year-old man visited our hospital with a complaint of right renal incidentaloma which was pointed out on abdominal ultrasonography for a medical check-up. Abdominal computed tomography showed a renal...
2.
Nishiyama R, Kanatani I, Oka H, Kimakura H, Ichijima K
Hinyokika Kiyo
. 2012 Jan;
57(12):693-6.
PMID: 22240303
A 77-year-old man visited our hospital with a chief complaint of asymptomatic gross hematuria. He was diagnosed with right renal pelvic tumor (7 cm) involving right renal hilar and inter-aortocaval...
3.
Kanatani I, Lin X, Yuan X, Manorek G, Shang X, Cheung L, et al.
Cancer Chemother Pharmacol
. 2011 Feb;
68(4):979-90.
PMID: 21327682
Purpose: Luteinizing hormone receptor (LHR) is found in abundance on human ovarian, breast, endometrial and prostate carcinomas but at only low levels on non-gonadal tissues. To selectively kill LHR-expressing tumors,...
4.
Yuan X, Lin X, Manorek G, Kanatani I, Cheung L, Rosenblum M, et al.
Mol Cancer Ther
. 2009 Jul;
8(7):1906-15.
PMID: 19567823
Using gene expression profiling, others and we have recently found that claudin-3 (CLDN3) and claudin-4 (CLDN4) are two of the most highly and consistently up-regulated genes in ovarian carcinomas. Because...
5.
Imamura M, Negoro H, Kanematsu A, Yamamoto S, Kimura Y, Nagane K, et al.
Am J Physiol Renal Physiol
. 2009 Apr;
297(1):F46-54.
PMID: 19386724
Overactive bladder is a highly prevalent clinical condition that is often caused by bladder outlet obstruction (BOO). Increased coupling of bladder smooth muscle cells (BSMC) via gap junctions has been...
6.
Kanatani I, Kanematsu A, Inatsugu Y, Imamura M, Negoro H, Ito N, et al.
Tissue Eng
. 2007 Oct;
13(12):2933-40.
PMID: 17961002
An ideal biomaterial for urethral reconstruction has not been developed. To create a urethral graft biomaterial with optimal biodegradability and biocompatibility, a copoly(L-lactide/epsilon-caprolactone) [P(LA/CL)] fabric tube was combined with a...
7.
Imamura M, Kanematsu A, Yamamoto S, Kimura Y, Kanatani I, Ito N, et al.
Am J Physiol Renal Physiol
. 2007 Jul;
293(4):F1007-17.
PMID: 17634401
Bladder hypertrophy is a general consequence of bladder outlet obstruction (BOO) and a typical phenomenon observed in clinical urologic diseases such as benign prostatic hyperplasia and neurogenic bladder. It is...
8.
Kanatani I, Ikai T, Okazaki A, Jo J, Yamamoto M, Imamura M, et al.
J Control Release
. 2006 Oct;
116(1):75-82.
PMID: 17055606
The feasibility and mechanism of gene delivery by pullulan-spermine, a recently developed cationic polysaccharide, were investigated. Pullulan-spermine-mediated transfection of plasmid DNA resulted in greatly reduced cytotoxicity and a 10-fold increase...
9.
Kanematsu A, Yamamoto S, Iwai-Kanai E, Kanatani I, Imamura M, Adam R, et al.
Am J Pathol
. 2005 Feb;
166(2):565-73.
PMID: 15681839
Tissue regeneration on acellular matrix grafts has great potential for therapeutic organ reconstruction. However, hollow organs such as the bladder require smooth muscle cell regeneration, the mechanisms of which are...
10.
Yamamoto S, Kunishima Y, Kanamaru S, Ito N, Kinoshita H, Kamoto T, et al.
Hinyokika Kiyo
. 2004 Dec;
50(10):673-83.
PMID: 15575217
In order to assess the ability of our protocol for antibiotic prophylaxis to prevent perioperative infections in urologic surgery, 1,353 operations of open and laparoscopic urologic surgery conducted in 21...